000 01400 a2200385 4500
005 20250516073023.0
264 0 _c20120705
008 201207s 0 0 eng d
022 _a1613-6829
024 7 _a10.1002/smll.201101879
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBasel, Matthew T
245 0 0 _aA cell-delivered and cell-activated SN38-dextran prodrug increases survival in a murine disseminated pancreatic cancer model.
_h[electronic resource]
260 _bSmall (Weinheim an der Bergstrasse, Germany)
_cMar 2012
300 _a913-20 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnimals
650 0 4 _aCamptothecin
_xadministration & dosage
650 0 4 _aDextrans
_xadministration & dosage
650 0 4 _aDisease Models, Animal
650 0 4 _aIrinotecan
650 0 4 _aMice
650 0 4 _aPancreatic Neoplasms
_xpathology
650 0 4 _aProdrugs
_xadministration & dosage
650 0 4 _aRabbits
700 1 _aBalivada, Sivasai
700 1 _aShrestha, Tej B
700 1 _aSeo, Gwi-Moon
700 1 _aPyle, Marla M
700 1 _aTamura, Masaaki
700 1 _aBossmann, Stefan H
700 1 _aTroyer, Deryl L
773 0 _tSmall (Weinheim an der Bergstrasse, Germany)
_gvol. 8
_gno. 6
_gp. 913-20
856 4 0 _uhttps://doi.org/10.1002/smll.201101879
_zAvailable from publisher's website
999 _c21454582
_d21454582